4Girard T, Treves S, Voronkov E, et al. Molecular genetic testing for malignant hyperthermia susceptibility. Anesthesiology, 2004, 100: 1076-1080.
5Sambuughin N, Sei Y, Gallagher KL, et al. North American malignant hyperthermia population: screening of the ryanodine receptor gene and identification of novel mutations. Anaesthesiology, 2001, 8:2055-2062.
6Gunilla I, Eva RT. Comparison between the European and North American protocols for diagnosis of malignant hyperthermia susceptibility in humans. Anesth Analg, 1999, 88:1155-1160.
7Hopkins PM. Malignant hyperthermia: advances in clinical management and diagnosis. Br J Anaesth, 2000, 85 : 118-128.
